AF
BPMC

Advisornet Financial’s Blueprint Medicines BPMC Stock Holding History

Advisornet Financial’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-127
Closed -$16.3K – 2248
2025
Q2 		$16.3K Buy
127
+8
+7% +$831 ﹤0.01% 1342
2025
Q1 		$10.5K Hold
119
– – ﹤0.01% 1394
2024
Q4 		$10.4K Sell
119
-15
-11% -$1.37K ﹤0.01% 1317
2024
Q3 		$12.4K Buy
134
+119
+793% +$11.8K ﹤0.01% 1352
2024
Q2 		$1.62K Hold
15
– – ﹤0.01% 1676
2024
Q1 		$1.42K Buy
+15
New +$1.29K ﹤0.01% 1667

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Advisornet Financial's BPMC Position: Q3 2025 in Review

Advisornet Financial sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 127 shares — an estimated $16.3K sold.

Advisornet Financial first reported a position in BPMC in Q1 2024 and held it in 6 quarters. The position peaked at $16.3K in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Advisornet Financial reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Advisornet Financial sold 127 Blueprint Medicines shares in Q3 2025, an estimated $16.3K.
  • Advisornet Financial first reported a position in Blueprint Medicines in Q1 2024 and held it in 6 quarters.
  • Advisornet Financial's Blueprint Medicines position peaked at $16.3K in Q2 2025.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Advisornet Financial's 13F filing for Q3 2025, filed 9 Oct 2025.